Part I: Biotech Deals — Creating Optimal Licensing and Partnering Arrangements

ABL Bio doubles down on self-sustainable growth beyond licensing deals

ABL Bio is seeking to transform itself from a licensing-focused biotech company into a globally competitive drug developer while advancing b

Special Edition: The Best of BPI, Part 2

BioProcess International's premiere digital edition featuring business, technical, peer-review and insights for biomanufacturing professiona

Innovative Insights: Legal Updates in Life Sciences

Teaching case study analyzes Raízen's dilemma: licensing vs. direct investment in second-generation ethanol expansion

Este caso para ensino analisa o dilema da Raízen na expansão internacional do etanol de segunda geração. A investigação revela o conflito en

Taking the Pulse of BioPharma: The Industry Today and Trends of Tomorrow

China's biotech rise: A case study in multiple myeloma drug development

A drug for multiple myeloma should have been an early warning that China is racing ahead in biotech